These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22688116)

  • 1. [Severely abnormal electroencephalogram in two patients who were treated with cefepime].
    Shirota Y; Ohtomo R; Hanajima R; Terao Y; Tsutsumi R; Tsuji S
    Rinsho Shinkeigaku; 2012; 52(5):356-9. PubMed ID: 22688116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pseudoperiodic EEG heralding a cefepime-induced encephalopathy].
    Sagot N; De Broucker T; Esquivel-Walls E; Rouvel A
    Rev Neurol (Paris); 2007 Nov; 163(11):1122-3. PubMed ID: 18033055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cefepime-induced encephalopathy in patients with renal failure].
    Martín Herrera C; Navarro M
    Nefrologia; 2009; 29(2):181. PubMed ID: 19396333
    [No Abstract]   [Full Text] [Related]  

  • 4. [A case of Cefepime encephalopathy, being difficult to distinguish from non-convulsive status epilepticus during the treatment of bacterial meningitis].
    Toda Y; Yamazaki M; Ota T; Fujisawa Y; Kimura K
    Rinsho Shinkeigaku; 2016 Oct; 56(10):678-683. PubMed ID: 27680224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefepime-induced encephalopathy in end-stage renal disease patients.
    Nakagawa R; Sato K; Uesaka Y; Mitsuki T; Kondo K; Wake A; Ubara Y; Kanzaki M
    J Neurol Sci; 2017 May; 376():123-128. PubMed ID: 28431597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefepime-related encephalopathy in peritoneal dialysis patients.
    Lin CJ; Chen SP; Wang SJ; Fuh JL
    J Chin Med Assoc; 2011 Feb; 74(2):87-90. PubMed ID: 21354086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefepime-induced encephalopathy in a COVID-19 patient: a case report.
    Nakamura T; Yatabe T; Kuriyama N; Hiraiwa T; Matsumoto K; Nishida O
    J Anesth; 2022 Jun; 36(3):432-435. PubMed ID: 35487992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal failure is a risk factor for cefepime-induced encephalopathy.
    Garces EO; Andrade de Anzambuja MF; da Silva D; Bragatti JA; Jacoby T; Saldanha Thomé F
    J Nephrol; 2008; 21(4):526-34. PubMed ID: 18651542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefepime-induced neurotoxicity: a systematic review.
    Payne LE; Gagnon DJ; Riker RR; Seder DB; Glisic EK; Morris JG; Fraser GL
    Crit Care; 2017 Nov; 21(1):276. PubMed ID: 29137682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefepime Neurotoxicity in Patients With Normal Renal Function: An Overlooked Cause of Encephalopathy in the Intensive Care Unit.
    Alagha Z; Crow S; Abdeen AMZ; Alastal M; Alastal A
    J Investig Med High Impact Case Rep; 2024; 12():23247096241259534. PubMed ID: 39068595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefepime Induced Encephalopathy in a Non-dialysis Dependent Chronic Kidney Disease Patient: A Case Report.
    Muniandy G; Kamaruzaman L; Jan TH; Mohd R; Neesam MT; Fong Voon K; Pau Kiew B; Mustafar R
    Acta Med Indones; 2023 Jan; 55(1):78-82. PubMed ID: 36999269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varied responses to benzodiazepine treatment in cephalosporin-related generalized periodic discharges.
    Liu HY; Chou CC; Yen DJ; Yu HY
    Epileptic Disord; 2016 Dec; 18(4):399-407. PubMed ID: 27818367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe but reversible encephalopathy associated with cefepime.
    Jallon P; Fankhauser L; Du Pasquier R; Coeytaux A; Picard F; Hefft S; Assal F
    Neurophysiol Clin; 2000 Dec; 30(6):383-6. PubMed ID: 11191931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefepime neurotoxicity despite renal adjusted dosing.
    Gangireddy VG; Mitchell LC; Coleman T
    Scand J Infect Dis; 2011 Oct; 43(10):827-9. PubMed ID: 21604923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefepime-induced nonconvulsive status epilepticus: case report and review.
    Thabet F; Al Maghrabi M; Al Barraq A; Tabarki B
    Neurocrit Care; 2009; 10(3):347-51. PubMed ID: 19034700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cefepime-induced encephalopathy: clinical and electroencephalographic features in seven patients].
    Bragatti JA; Rossato R; Ziomkowski S; Kliemann FA
    Arq Neuropsiquiatr; 2005 Mar; 63(1):87-92. PubMed ID: 15830071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, Electroencephalographic Features and Prognostic Factors of Cefepime-Induced Neurotoxicity: A Retrospective Study.
    Li HT; Lee CH; Wu T; Cheng MY; Tseng WJ; Chang CW; Hsieh HY; Chiang HI; Lin CY; Chang BL; Lin WR; Lim SN
    Neurocrit Care; 2019 Oct; 31(2):329-337. PubMed ID: 30756319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged Cefepime-Induced Neurotoxicity in a Patient with End-Stage Renal Disease.
    Nguyen DD; Lai S
    Am J Case Rep; 2022 Jan; 23():e934083. PubMed ID: 35067669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical case of the month. Antibiotics and hemodialysis: three cases of neurotoxicity from Maxipime].
    Parotte MC; Krzesinski JM
    Rev Med Liege; 2008 Mar; 63(3):119-21. PubMed ID: 18561766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible coma secondary to cefepime neurotoxicity.
    Abanades S; Nolla J; Rodríguez-Campello A; Pedro C; Valls A; Farré M
    Ann Pharmacother; 2004 Apr; 38(4):606-8. PubMed ID: 14982986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.